Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers

Bohnenkamp H, Coleman J, Burchell J, Taylor-Papadimitriou J, Noll T (2004)
Cellular Immunology 231(1-2): 112-125.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ;
Publishing Year
ISSN
PUB-ID

Cite this

Bohnenkamp H, Coleman J, Burchell J, Taylor-Papadimitriou J, Noll T. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers. Cellular Immunology. 2004;231(1-2):112-125.
Bohnenkamp, H., Coleman, J., Burchell, J., Taylor-Papadimitriou, J., & Noll, T. (2004). Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers. Cellular Immunology, 231(1-2), 112-125.
Bohnenkamp, H., Coleman, J., Burchell, J., Taylor-Papadimitriou, J., and Noll, T. (2004). Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers. Cellular Immunology 231, 112-125.
Bohnenkamp, H., et al., 2004. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers. Cellular Immunology, 231(1-2), p 112-125.
H. Bohnenkamp, et al., “Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers”, Cellular Immunology, vol. 231, 2004, pp. 112-125.
Bohnenkamp, H., Coleman, J., Burchell, J., Taylor-Papadimitriou, J., Noll, T.: Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers. Cellular Immunology. 231, 112-125 (2004).
Bohnenkamp, H, Coleman, J, Burchell, J, Taylor-Papadimitriou, J, and Noll, Thomas. “Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers”. Cellular Immunology 231.1-2 (2004): 112-125.
This data publication is cited in the following publications:
This publication cites the following data publications:

11 Citations in Europe PMC

Data provided by Europe PubMed Central.

Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells.
Zhang P, Yi S, Li X, Liu R, Jiang H, Huang Z, Liu Y, Wu J, Huang Y., PLoS ONE 9(7), 2014
PMID: 25036145
MUC1 immunotherapy.
Beatson RE, Taylor-Papadimitriou J, Burchell JM., Immunotherapy 2(3), 2010
PMID: 20635898
Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice.
Tian F, Wang L, Qin W, Wang F, Song B, Li Y, Wen W, Zhang Z, Zhu K, Zhang Q, Lee C, Zhong W, Guo Y, Wang H., Cancer Lett. 271(2), 2008
PMID: 18675506
Immunisation with 'naive' syngeneic dendritic cells protects mice from tumour challenge.
Grimshaw MJ, Papazisis K, Picco G, Bohnenkamp H, Noll T, Taylor-Papadimitriou J, Burchell J., Br. J. Cancer 98(4), 2008
PMID: 18253127
Current approaches in dendritic cell generation and future implications for cancer immunotherapy.
Tuyaerts S, Aerts JL, Corthals J, Neyns B, Heirman C, Breckpot K, Thielemans K, Bonehill A., Cancer Immunol. Immunother. 56(10), 2007
PMID: 17503040
The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2.
Mitchell MS, Lund TA, Sewell AK, Marincola FM, Paul E, Schroder K, Wilson DB, Kan-Mitchell J., Cancer Immunol. Immunother. 56(3), 2007
PMID: 16874487
Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8+ T cells by dendritic cells loaded with killed allogeneic breast cancer cells.
Saito H, Dubsky P, Dantin C, Finn OJ, Banchereau J, Palucka AK., Breast Cancer Res. 8(6), 2006
PMID: 17129372

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 15919376
PubMed | Europe PMC

Search this title in

Google Scholar